Video
Author(s):
Focusing on clinical trials and novel therapies, Rami Komrokji, MD, and Ruben Mesa, MD, share their hope for the future management of essential thrombocythemia and polycythemia vera.
Jakafi, Pegasys Combination Beneficial in Newly Diagnosed Polycythemia Vera
FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis
Education on MPN Symptoms, Treatments Leads to Greater Involvement in Care
LeVar Burton Helping the MPN Community Through Advocacy and Storytelling
Vonjo Improves Thrombocytopenia, Anemia in Patients With Myelofibrosis
A True Partner in Cancer Healing